Oak Ridge National Laboratory

ORNL launches rapid access licensing program to speed up COVID-19 solutions

19-Jun-2020 1:55 PM EDT, by Oak Ridge National Laboratory

Newswise — The Department of Energy’s Oak Ridge National Laboratory has launched a program designed to accelerate deployment of innovations that may help fight the COVID-19 pandemic. The COVID-19 Rapid Access Licensing Program will allow companies to license these select technologies at no cost for one year.   

“As ORNL races to find solutions to the COVID-19 pandemic, the Technology Transfer Office is working to provide streamlined processes and easy access to intellectual property so that companies can work with ORNL to quickly address this public health crisis,” said Jennifer Caldwell, ORNL’s group leader for technology commercialization. 

In collaboration with researchers, ORNL’s Technology Transfer Office is creating a growing portfolio of inventions available to license through the program. The licenses are nonexclusive, meaning more than one person can hold the right to use the technology. Interested licensees must demonstrate intent to use ORNL’s innovations to address COVID-19 and commit to disseminating resulting products as widely and quickly as possible. Only U.S. entities, companies and universities are eligible. 

Alternative licenses will be available for companies creating products that require exclusivity to support large development investments, such as for diagnostic platforms, drug delivery systems, therapies and vaccines. 

ORNL has quickly responded to the COVID-19 pandemic through its research efforts in computational science, advanced manufacturing, data science and neutron science. Inventions available to license through this program represent ORNL strengths in these areas as well as in areas ranging from biological sciences to spectrometry to next-generation materials.    

“ORNL has shown leadership in adapting our research, operations and community engagement efforts to combat COVID-19 and mitigate its effects on our community,” said ORNL Director Thomas Zacharia. “We are pleased to now offer industry partners a quicker and easier way to use our strong technology portfolio for COVID-19 solutions.” 

ORNL joins DOE national laboratories across the nation in the fight against COVID-19. Additional information on DOE technologies, facilities, experts and resources accessible to partners working against the virus is available through the recently announced Lab Partnering Service COVID-19 Portal

UT-Battelle manages ORNL for DOE’s Office of Science. The single largest supporter of basic research in the physical sciences in the United States, the Office of Science is working to address some of the most pressing challenges of our time. For more information, please visit https://www.energy.gov/science/



Filters close

Showing results

110 of 6128
Released: 5-Aug-2021 10:55 AM EDT
AMSSM Partners with White House and 11 Organizations to Encourage Vaccine Conversations During Sports Physicals
American Medical Society for Sports Medicine (AMSSM)

AMSSM and 11 other leading sports and medical organizations signed on to a consensus statement to encourage healthcare providers to include conversations about COVID-19 vaccinations as part of the pre-participation physical.

Newswise: August Issue of Issue of The American Journal of Gastroenterology Includes Diet-Associated NAFLD Risk and Increased Risk of Mortality from COVID-19 Among PPI Users
Released: 5-Aug-2021 9:25 AM EDT
August Issue of Issue of The American Journal of Gastroenterology Includes Diet-Associated NAFLD Risk and Increased Risk of Mortality from COVID-19 Among PPI Users
American College of Gastroenterology (ACG)

The August issue of The American Journal of Gastroenterology includes clinical discussions of diet-associated NAFLD risk and increased risk of mortality from COVID-19 among PPI users. In addition, this issue features clinical research and reviews on IBS, gender barriers for CRC screening, hepatitis C, eosinophilic esophagitis, and more.

Released: 5-Aug-2021 8:45 AM EDT
Research Reveals that Flu Shot Protects Against Severe Effects of COVID-19
University of Miami Health System, Miller School of Medicine

In a newly published study, physician-scientists at the University of Miami Miller School of Medicine have shown that the flu vaccine may provide vital protection against COVID-19.

Released: 5-Aug-2021 8:45 AM EDT
Persistent COVID-19 Infections in Immunocompromised People May Give Rise to Variants of Concern
Fred Hutchinson Cancer Research Center

In an article in the New England Journal of Medicine, scientists from Fred Hutchinson Cancer Research Center, Johns Hopkins Bloomberg School of Medicine, the U.S. Military HIV Research Program and the Institute for Global Health and Infectious Diseases at the University of North Carolina urged increased attention to persistent COVID-19 infections in immunocompromised people.

Newswise: Novel Model Predicts COVID-19 Outbreak Two Weeks Ahead of Time
Released: 5-Aug-2021 8:30 AM EDT
Novel Model Predicts COVID-19 Outbreak Two Weeks Ahead of Time
Florida Atlantic University

People’s social behavior, reflected in their mobility data, is providing scientists with a way to forecast the spread of COVID-19 nationwide at the county level. Researchers have developed the first data-driven deep learning model with the potential to predict an outbreak in COVID-19 cases two weeks in advance. Feeding the mobility data to epidemiological forecasting models helps to estimate COVID-19 growth as well as evaluating the effects of government policies such as mandating masks on the spread of COVID-19.

Released: 4-Aug-2021 5:05 PM EDT
Canadian-Led International Study: Full-Dose Blood Thinners Benefit Moderately Ill COVID-19 Patients
University of Manitoba

The investigators discovered that in moderately ill patients full-dose heparin reduced the need for organ support compared to those who received lower-dose heparin.

Released: 4-Aug-2021 4:00 PM EDT
CDC withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test does not mean the test failed
Newswise

Social media is now rife with claims about why the CDC is withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test after December 2021.

Newswise: Public
Released: 4-Aug-2021 2:05 PM EDT
A Study Reveals What Triggers Lung Damage During COVID-19
The Korea Advanced Institute of Science and Technology (KAIST)

A KAIST immunology research team found that a specific subtype of macrophages that originated from blood monocytes plays a key role in the hyper-inflammatory response in SARS-CoV-2 infected lungs, by performing single-cell RNA sequencing of bronchoalveolar lavage fluid cells.

Released: 4-Aug-2021 1:00 PM EDT
American Society of Anesthesiologists and Anesthesia Patient Safety Foundation Say Preoperative Testing for COVID-19 is Essential, Regardless of Vaccination
American Society of Anesthesiologists (ASA)

All patients undergoing non-emergency surgeries or procedures should continue to have preoperative polymerase chain reaction (PCR) testing for SARS-CoV-2, irrespective of vaccination status, according to an updated guidance from the American Society of Anesthesiologists and Anesthesia Patient Safety Foundation.

Newswise: FAU Expert Answers Questions about Delta Variant, Vaccines and Public Safety
Released: 4-Aug-2021 12:35 PM EDT
FAU Expert Answers Questions about Delta Variant, Vaccines and Public Safety
Florida Atlantic University

Florida Atlantic University’s Joanna Drowos, D.O., M.P.H., M.B.A., Schmidt College of Medicine, provides answers to some of the most frequently asked questions regarding the COVID-19 Delta variant, vaccines and public safety measures.


Showing results

110 of 6128

close
3.15019